Related Experiment Video

Updated: Apr 21, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.8K

Aspirin and NSAIDs for breast cancer chemoprevention

Eugenia Ch Yiannakopoulou1

  • 1Department of Medical Laboratories, Faculty of Health and Caring Professions, Technological Educational Institute of Athens, Athens, Greece.

European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|November 8, 2014
PubMed

Insights

Non-steroidal anti-inflammatory drugs (NSAIDs) show promise for breast cancer chemoprevention, particularly for estrogen receptor-negative types. This review explores their COX-2-independent mechanisms beyond prostaglandin inhibition.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Novel breast cancer chemoprevention strategies are crucial, especially for estrogen receptor-negative subtypes where options are limited.
  • Tamoxifen is the sole approved drug for estrogen receptor-positive breast cancer chemoprevention.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) are linked to reduced breast cancer risk, but mechanisms remain unclear.

Purpose of the Study:

  • To review the evidence on cyclooxygenase-2 (COX-2)-independent mechanisms of action for NSAIDs in breast cancer.
  • To explore how aspirin, salicylates, and other NSAIDs may prevent breast cancer through pathways beyond prostaglandin synthesis.

Main Methods:

  • Literature review synthesizing existing research on NSAID mechanisms in breast cancer.
  • Analysis of studies investigating COX-2-independent effects of NSAIDs.
  • Examination of NSAID interactions with cellular signaling pathways.

Main Results:

  • NSAIDs inhibit cyclooxygenases, reducing prostaglandin, prostacyclin, and thromboxane formation.
  • NSAIDs demonstrate additional biological effects, including reactive oxygen species generation.
  • NSAIDs can inhibit nuclear factor-κB-mediated signals, a pathway implicated in cancer.

Conclusions:

  • NSAIDs possess multiple COX-2-independent mechanisms that may contribute to breast cancer chemoprevention.
  • Further research into these pathways could lead to new therapeutic strategies for breast cancer prevention.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.6K

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Cancer Prevention02:59

Cancer Prevention

3.1K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
793
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
929
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K